Matina's BioPharma announces 1-for-15 reverse stock split effective Sept 28, 2026

Matinas BioPharma Holdings, Inc.

Board approved 1-for-15 reverse stock split; effective 12:01 a.m. ET on Sept 28, 2026.
Trading on split-adjusted basis under symbol MTNB begins Sept 28; new CUSIP 576810 402.
No fractional shares issued; stockholders receive proportional cash instead.
Percentage ownership and voting power unchanged; authorized shares and par value unaffected.
Company notes no assurance split will enable continued NYSE American listing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.